Chloe L. Thio

13.4k total citations · 3 hit papers
154 papers, 9.4k citations indexed

About

Chloe L. Thio is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Chloe L. Thio has authored 154 papers receiving a total of 9.4k indexed citations (citations by other indexed papers that have themselves been cited), including 122 papers in Epidemiology, 116 papers in Hepatology and 51 papers in Infectious Diseases. Recurrent topics in Chloe L. Thio's work include Hepatitis C virus research (115 papers), Hepatitis B Virus Studies (95 papers) and Liver Disease Diagnosis and Treatment (52 papers). Chloe L. Thio is often cited by papers focused on Hepatitis C virus research (115 papers), Hepatitis B Virus Studies (95 papers) and Liver Disease Diagnosis and Treatment (52 papers). Chloe L. Thio collaborates with scholars based in United States, Australia and United Kingdom. Chloe L. Thio's co-authors include David L. Thomas, Mary Carrington, James J. Goedert, Eric C. Seaberg, Christopher J. Hoffmann, Jacquie Astemborski, Gregory D. Kirk, Maureen P. Martin, Stephen J. O’Brien and Salim I. Khakoo and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Chloe L. Thio

145 papers receiving 9.1k citations

Hit Papers

Genetic variation in IL28B and spontaneous clearance of h... 2002 2026 2010 2018 2009 2004 2002 500 1000 1.5k

Peers

Chloe L. Thio
Margaret James Koziel United States
Jacquie Astemborski United States
Shyam Kottilil United States
F. Blaine Hollinger United States
Harvey J. Alter United States
Andrea L. Cox United States
C. Trépo France
Margaret James Koziel United States
Chloe L. Thio
Citations per year, relative to Chloe L. Thio Chloe L. Thio (= 1×) peers Margaret James Koziel

Countries citing papers authored by Chloe L. Thio

Since Specialization
Citations

This map shows the geographic impact of Chloe L. Thio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chloe L. Thio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chloe L. Thio more than expected).

Fields of papers citing papers by Chloe L. Thio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chloe L. Thio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chloe L. Thio. The network helps show where Chloe L. Thio may publish in the future.

Co-authorship network of co-authors of Chloe L. Thio

This figure shows the co-authorship network connecting the top 25 collaborators of Chloe L. Thio. A scholar is included among the top collaborators of Chloe L. Thio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chloe L. Thio. Chloe L. Thio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anderson, Mark, Gavin Cloherty, Hyon S. Hwang, et al.. (2025). Transcription of hepatitis B surface antigen shifts from cccDNA to integrated HBV DNA during treatment. Journal of Clinical Investigation. 135(6). 1 indexed citations
2.
Jiang, Chenkai, et al.. (2025). High-dimensional droplet digital PCR of multiple hepatitis B splice variants in serum, liver, and tissue culture. Journal of Virological Methods. 336. 115155–115155.
3.
Thomas, David L., Gregory D. Kirk, Shruti H. Mehta, et al.. (2024). Hepatitis B Virus DNA and RNA Persist in Liver After Serologic Recovery in Persons With Hepatitis C Virus. The Journal of Infectious Diseases. 230(6). 1352–1356. 1 indexed citations
4.
Iqbal, Hussain Syed, Mark G. Anderson, Allison M. McFall, et al.. (2024). Hepatitis B Virus in People who Inject Drugs and Men who Have Sex With Men With HIV in India: A Cross-sectional Study. Open Forum Infectious Diseases. 11(7). ofae350–ofae350.
5.
Hwang, Hyon S., Jeffrey Quinn, Mark Sulkowski, et al.. (2022). Integrated hepatitis B virus DNA maintains surface antigen production during antiviral treatment. Journal of Clinical Investigation. 132(18). 45 indexed citations
6.
7.
Breskin, Alexander, Daniel Westreich, Christopher B. Hurt, et al.. (2019). The Effects of Hepatitis C Treatment Eligibility Criteria on All-cause Mortality Among People With Human Immunodeficiency Virus. Clinical Infectious Diseases. 69(9). 1613–1620. 10 indexed citations
9.
Bollinger, Robert C., Chloe L. Thio, Mark Sulkowski, et al.. (2019). Addressing the global burden of hepatitis B virus while developing long-acting injectables for the prevention and treatment of HIV. The Lancet HIV. 7(6). e443–e448. 30 indexed citations
10.
Price, Jennifer C., Eric C. Seaberg, John Phair, et al.. (2016). Brief Report: Highly Active Antiretroviral Therapy Mitigates Liver Disease in HIV Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 72(3). 319–323. 4 indexed citations
11.
Li, Yijia, Jing Xie, Yang Han, et al.. (2016). Combination Antiretroviral Therapy Is Associated With Reduction in Liver Fibrosis Scores in HIV-1-Infected Subjects. Medicine. 95(5). e2660–e2660. 9 indexed citations
12.
Falade‐Nwulia, Oluwaseun, Eric C. Seaberg, Anna E. Snider, et al.. (2015). Incident Hepatitis B Virus Infection in HIV-Infected and HIV-Uninfected Men Who Have Sex With Men From Pre-HAART to HAART Periods. Annals of Internal Medicine. 1 indexed citations
13.
Thio, Chloe L., Nan Guo, Chan Xie, Kenrad E. Nelson, & Stephan Ehrhardt. (2015). Global elimination of mother-to-child transmission of hepatitis B: revisiting the current strategy. The Lancet Infectious Diseases. 15(8). 981–985. 73 indexed citations
14.
Price, Jennifer C., Eric C. Seaberg, Rachel Latanich, et al.. (2014). Risk Factors for Fatty Liver in the Multicenter AIDS Cohort Study. The American Journal of Gastroenterology. 109(5). 695–704. 100 indexed citations
15.
Kuniholm, Mark H., Kathryn Anastos, Andrea Kovács, et al.. (2013). Relation of HLA class I and II supertypes with spontaneous clearance of hepatitis C virus. Genes and Immunity. 14(5). 330–335. 6 indexed citations
16.
Price, Jennifer C., et al.. (2012). HIV Monoinfection Is Associated With Increased Aspartate Aminotransferase-to-Platelet Ratio Index, a Surrogate Marker for Hepatic Fibrosis. The Journal of Infectious Diseases. 205(6). 1005–1013. 52 indexed citations
17.
Thio, Chloe L.. (2010). Virology and clinical sequelae of drug-resistant HBV in HIV-HBV-coinfected patients on highly active antiretroviral therapy. Antiviral Therapy. 15(3 Part B). 487–491. 5 indexed citations
18.
Thio, Chloe L.. (2008). Management of Patients with Co-Morbid Conditions. 46th Annual Meeting.
19.
Hoffmann, Christopher J., Katherine Fielding, Salome Charalambous, et al.. (2008). Antiretroviral therapy using zidovudine, lamivudine, and efavirenz in South Africa: tolerability and clinical events. AIDS. 22(1). 67–74. 60 indexed citations
20.
Thio, Chloe L., Jacquie Astemborski, Arman Bashirova, et al.. (2006). Genetic Protection against Hepatitis B Virus Conferred by CCR5Δ32 : Evidence that CCR5 Contributes to Viral Persistence. Journal of Virology. 81(2). 441–445. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026